Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway

Even with recent advances in therapy regimen, multiple myeloma patients commonly develop drug resistance and relapse. The relevance of targeting the PD-1/PD-L1 axis has been demonstrated in pre-clinical models...

Source: Journal of Hematology and Oncology - March 27, 2018 Category: Hematology Authors: Rosemarie Tremblay-LeMay, Nasrin Rastgoo and Hong Chang Tags: Review Source Type: research